Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS 41002 (Mometasone Furoate) in Atopic Eczema
NCT01119313Phase 2Completed
- Sponsor
- Almirall
- Start
- Feb 2010
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of LAS 41002 in atopic dermatitis (AD), sponsored by Almirall. Started Feb 2010; status: completed.
02
Drugs
LAS 41002
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01119313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119313.